Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds that impacted UnitedHealth ...

Cigna Group (CI) reported their Q2 and H1 2025 earnings, highlighting significant growth in both sales and revenue year-over-year, although Q2 net income saw a slight dip. Over the past week, Cigna's ...

Stocks in a Bloodbath. The Cigna Group (NYSE:CI) is one of the worst-performing stocks on Thursday. The Cigna Group declined ...

Cigna's recent market performance paints a complex picture, dropping 5.18% despite mixed analyst ratings. Institutional ...

Cigna Group reaffirmed its 2025 guidance Thursday on the back of solid growth within its Evernorth businesses and limited ...

Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read an analysis of HUM stock now.

Medirom stock soared over 79% pre-market after announcing a deal to install World ID devices in its salons across Japan.

Revenue reached $67.2 billion, beating analyst estimates by 7.3% (non-GAAP) and growing 11% year over year. Adjusted earnings per share (EPS) rose to $7.20, surpassing expectations and EPS increased 7 ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.

In today’s higher-tariff world, where political and geopolitical clashes are harsh, you might want to take your stock ...

Cigna Group recently reported a robust financial performance with second quarter revenues reaching US$67.18 billion and ...

The Cigna Group (NYSE:CI) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. The company reported solid earnings in the first quarter of 2025, with revenues of $65.4 ...